CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 663 participants.
Also called NCT07276711
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 663 participants
- Sponsor
- Registry
-
NCT07276711
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07276711. Randomized; single masking; primary purpose treatment. Start 2026-05-12 (actual); primary completion 2028-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
- Condition
- Aortic Valve Stenosis
- Condition
- Aortic Stenosis
- Condition
- Aortic Valve Disease
- Intervention (Device)
- EmStop Embolic Protection System
- Intervention (Device)
- Boston Scientific Sentinel
- Lead sponsor
- EmStop Inc
- Collaborator
- Bright Research Partners
Record details
- Record id
cardio:ct-nct07276711- Content hash
476c01bc40bab0efe7160d5324d3a470433fed4903ac410d78d56d8e62f90c9f